Foregen

Foregen Foregen is a non-profit organization founded to research and implement regenerative medical therapies for circumcised males.

Foregen’s work entails:

Negotiating with research institutes in the field of Regenerative medicine to promote dermal Regeneration for the genitally injured;
Organizing research and clinical trials necessary to make regenerative medical applications a reality;
Fund-raising for the clinical trials needed to make regenerative solutions a reality.

29/08/2026

This analogy illustrates the complexity of restoring essential infrastructure, akin to rebuilding the neural and vascular pathways. The process involves establishing main conduits first, followed by the intricate network of capillaries, presenting a beautiful challenge in regenerative tissue research.

27/08/2026

Foregen is pioneering regenerative medicine to restore the fo****in's neural and vascular infrastructure. Leveraging research from rat and sheep models, we aim for human trials following AMA and FDA guidelines. Recellularization is a critical step for successful organ transplantation. ****inRestoration

24/08/2026

This video explains how natural cues in a construct guide nerve fiber reinnervation. The ultimate goal in regenerative medicine is to create a biomechanically identical recellularized tissue. ****inRestoration

20/08/2026

Motivated by concerns about non-consensual surgeries, this individual sought to support the amelioration of the circumcision issue. Connecting with Foregen in 2020, they offered fundraising support, which was warmly received. This led to managing Foregen's social media presence, advancing the mission of regenerative tissue research.

17/08/2026

Understanding extracellular matrix regeneration is like renovating a building. New cellular workers, representing Foregen's approach, arrive wearing company-specific attire, signifying organized and precise tissue restoration.

Our Q3 2026 donor call transcript is now live! Fibroblasts and stem cells are repopulating our decellularized scaffolds ...
16/08/2026

Our Q3 2026 donor call transcript is now live! Fibroblasts and stem cells are repopulating our decellularized scaffolds reliably. Keratinocytes are the remaining challenge in milestone three. Read the full call:

Foregen's Q3 2026 donor call transcript: fo****in regeneration progress from the Slovakia lab, recellularization milestone 3, bioreactor work, and Q&A.

15/08/2026

This segment features individuals who embody passion and commitment, highlighting the intelligence and dedication of the current generation. Their energy fuels our work in regenerative tissue research.

14/08/2026

Foregen utilizes regenerative tissue research to restore the fo****in's neural and vascular infrastructure. This approach, symbolized by a unfurling rose bud, represents frontier science and hope for reversing circumcision. ****inRestoration

13/08/2026

Foregen is pioneering regenerative medicine to restore the fo****in's neural and vascular infrastructure. Our research involves decellularization and recellularization protocols, utilizing bioreactors to cultivate mature tissue constructs for potential human trials.

12/08/2026

Foregen is leveraging bioreactor technology to revascularize tissue. By creating hypoxic, low-oxygen environments, we incite cells to grow new vascularity, advancing our research in regenerative medicine.

Address

Piestany
921 01

Alerts

Be the first to know and let us send you an email when Foregen posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share